# Portfolio Audit B — Playbook With Phase 13A Diversifier Modules

Research/simulation only. No live trading, broker adapters, order routing, webhooks, credential storage, automated execution, or LLM-driven trade decisions.

## Scope

Diagnostic portfolio audit only. It uses existing registry and phase outputs, does not generate signals, does not change official gates, does not promote candidates, and does not approve paper trading.

## Summary

- Selected modules: `20`
- Portfolio rows: `21`
- Next action: `keep_phase13a_as_diversifier_and_search_more_uncorrelated_modules`
- Rationale: Phase 13A improves activity or correlation, but fold/concentration gates remain insufficient.
- Paper trading approved: `false`

## Phase 13A Impact Versus Audit A Best

| Mode | Active days Δ | Fold Δ | Best-day conc Δ | Best-trade conc Δ | Drawdown Δ | Correlation Δ | Role assessment |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | --- |
| raw_sum_diagnostic | 0 | 0.000 | -0.021 | -0.017 | -753.20 | 0.026 | diversifier_module |
| one_trade_at_a_time_chronological | 37 | 0.000 | -0.008 | -0.004 | 112.75 | 0.026 | diversifier_module |
| max_one_trade_per_session | 37 | -0.167 | -0.023 | -0.023 | -699.67 | 0.026 | diversifier_module |

## Portfolio Results

| Set | Mode | Net | Active days | Best-day conc | Best-trade conc | Positive folds | Label | Status |
| --- | --- | ---: | ---: | ---: | ---: | ---: | --- | --- |
| all_parked_modules_with_phase13a | one_trade_at_a_time_chronological | -3048.68 | 240 | 1.000 | 1.000 | 0.333 | portfolio_b_failed_negative | no_portfolio_benefit |
| all_parked_modules_with_phase13a | raw_sum_diagnostic | 28946.77 | 246 | 0.176 | 0.031 | 0.667 | portfolio_b_positive_but_concentrated | portfolio_still_nontradable |
| audit_a_best_plus_phase13a | raw_sum_diagnostic | 10486.15 | 246 | 0.083 | 0.086 | 0.833 | portfolio_b_positive_but_concentrated | phase13a_reduces_concentration |
| audit_a_best_reconstructed | raw_sum_diagnostic | 8724.15 | 246 | 0.104 | 0.104 | 0.833 | portfolio_b_positive_but_concentrated | portfolio_still_nontradable |
| greedy_low_correlation_with_phase13a | raw_sum_diagnostic | 8569.02 | 246 | 0.086 | 0.106 | 0.833 | portfolio_b_positive_but_concentrated | phase13a_reduces_concentration |
| greedy_low_correlation_with_phase13a | one_trade_at_a_time_chronological | 7418.02 | 243 | 0.123 | 0.122 | 0.667 | portfolio_b_positive_but_concentrated | phase13a_reduces_concentration |
| rare_plus_diversifier_modules | raw_sum_diagnostic | 6846.53 | 246 | 0.158 | 0.085 | 0.667 | portfolio_b_positive_but_concentrated | portfolio_still_nontradable |
| audit_a_best_plus_phase13a | one_trade_at_a_time_chronological | 6592.07 | 236 | 0.134 | 0.137 | 0.833 | portfolio_b_positive_but_concentrated | phase13a_reduces_concentration |
| top_cross_family_plus_phase13a | raw_sum_diagnostic | 6441.91 | 246 | 0.154 | 0.141 | 0.667 | portfolio_b_positive_but_concentrated | portfolio_still_nontradable |
| audit_a_best_reconstructed | one_trade_at_a_time_chronological | 6408.14 | 199 | 0.141 | 0.141 | 0.833 | portfolio_b_positive_but_concentrated | portfolio_still_nontradable |
| audit_a_best_reconstructed | max_one_trade_per_session | 5529.25 | 199 | 0.164 | 0.164 | 0.833 | portfolio_b_positive_but_concentrated | portfolio_still_nontradable |
| top_cross_family_plus_phase13a | one_trade_at_a_time_chronological | 4985.70 | 234 | 0.184 | 0.182 | 0.667 | portfolio_b_positive_but_concentrated | portfolio_still_nontradable |
| rare_plus_diversifier_modules | one_trade_at_a_time_chronological | 4691.38 | 198 | 0.188 | 0.124 | 0.667 | portfolio_b_positive_but_concentrated | portfolio_still_nontradable |
| audit_a_best_plus_phase13a | max_one_trade_per_session | 4133.65 | 236 | 0.140 | 0.140 | 0.667 | portfolio_b_positive_but_concentrated | phase13a_reduces_concentration |
| rare_plus_diversifier_modules | max_one_trade_per_session | 2739.78 | 198 | 0.212 | 0.212 | 0.500 | portfolio_b_positive_but_concentrated | portfolio_still_nontradable |
| top_cross_family_plus_phase13a | max_one_trade_per_session | 2399.63 | 234 | 0.175 | 0.175 | 0.500 | portfolio_b_positive_but_concentrated | portfolio_still_nontradable |
| diversifier_only_phase13a | raw_sum_diagnostic | 1762.00 | 246 | 0.343 | 0.171 | 0.500 | portfolio_b_positive_but_concentrated | portfolio_still_nontradable |
| greedy_low_correlation_with_phase13a | max_one_trade_per_session | 1077.83 | 243 | 0.539 | 0.539 | 0.500 | portfolio_b_positive_but_concentrated | portfolio_still_nontradable |
| all_parked_modules_with_phase13a | max_one_trade_per_session | 922.15 | 240 | 0.630 | 0.630 | 0.500 | portfolio_b_positive_but_concentrated | portfolio_still_nontradable |
| diversifier_only_phase13a | max_one_trade_per_session | 879.00 | 123 | 0.343 | 0.343 | 0.667 | portfolio_b_positive_but_concentrated | portfolio_still_nontradable |
| diversifier_only_phase13a | one_trade_at_a_time_chronological | 399.68 | 123 | 0.755 | 0.755 | 0.500 | portfolio_b_positive_but_concentrated | portfolio_still_nontradable |

## Interpretation

Phase 13A remains research-only. Portfolio Audit B reports diagnostic gate status only; no portfolio is paper-trading approved.
